Skip to main content

#162214

Anti-HSPB3 PAb

Cat. #162214

Anti-HSPB3 PAb

Cat. #: 162214

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: HSPB3

Class: Polyclonal

Application: WB ; IHC

Reactivity: Human

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Roy Quinlan

Institute: University of Durham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-HSPB3 PAb
  • Alternate name: HSP27, HSPL27, Heat shock 17 kDa protein (HSP 17), protein 3
  • Research fields: Cell biology
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Molecular weight: 20kDa, 150 residues
  • Reactivity: Human
  • Application: WB ; IHC
  • Description: A polyclonal antibody for HSPB3 also known as HSP27 or HSP27L. This antibody binds a site on the C-terminus of the protein. As it is a HSP27L antibody, this reagent can be used to confirm the presence of HSPB1 as well as HSPB3.
  • Immunogen: peptide crosslinked to KLH
  • Isotype: IgG

Target Details

  • Target: HSPB3
  • Target alternate names: HSP27, HSPL27, Heat shock 17 kDa protein (HSP 17), protein 3
  • Molecular weight: 20kDa, 150 residues
  • Target background: A small heat-shock protein. Small heat-shock proteins are characterized by a conserved sequence of 80 to 100 amino acids, often called the alpha-crystallin domain, and range in size from 12 to 43 kD in the monomeric state; as multimeric complexes, they range from 150 to 800 kD .

Applications

  • Application: WB ; IHC

Handling

  • Format: Liquid
  • Concentration: 1mg/ml
  • Unit size: 100 ug
  • Storage buffer: Serum plus azide (0.02%)
  • Storage conditions: -80° C
  • Shipping conditions: Dry ice

References

  • Gianniou DD, et al. 2023. Int J Mol Sci. 30
  • 24(3):2609. PMID: 36768927.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.